Meyka Pro banner
GRAIL Inc.

GRAIL Inc. Fundamental Analysis (NASDAQ: GRAL)

GRAL●NASDAQ
HealthcareMedical - Diagnostics & Research
$136.57
$3.94(2.97%)
U.S. Market opens in 13h 1m

GRAIL Inc. Fundamental Analysis (NASDAQ: GRAL)

GRAIL Inc. (NASDAQ: GRAL) shows moderate financial fundamentals with a PE ratio of -14.05, profit margin of -2.37%, and ROE of -15.88%. The company generates $0.2B in annual revenue with strong year-over-year growth of 17.18%.

Key Strengths

Cash Position14.63%
PEG Ratio-0.45
Current Ratio10.95

Areas of Concern

ROE-15.88%
Operating Margin-3.38%
We analyze GRAL's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -157.0/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-157.0/100

We analyze GRAL's fundamental strength across five key dimensions:

Efficiency Score

Weak

GRAL struggles to generate sufficient returns from assets.

ROA > 10%
-13.77%

Valuation Score

Excellent

GRAL trades at attractive valuation levels.

PE < 25
-14.05
PEG Ratio < 2
-0.45

Growth Score

Excellent

GRAL delivers strong and consistent growth momentum.

Revenue Growth > 5%
17.18%
EPS Growth > 10%
82.51%

Financial Health Score

Excellent

GRAL maintains a strong and stable balance sheet.

Debt/Equity < 1
0.04
Current Ratio > 1
10.95

Profitability Score

Weak

GRAL struggles to sustain strong margins.

ROE > 15%
-1588.40%
Net Margin ≥ 15%
-2.37%
Positive Free Cash Flow
No

Key Financial Metrics

Is GRAL Expensive or Cheap?

P/E Ratio

GRAL trades at -14.05 times earnings. This suggests potential undervaluation.

-14.05

PEG Ratio

When adjusting for growth, GRAL's PEG of -0.45 indicates potential undervaluation.

-0.45

Price to Book

The market values GRAIL Inc. at 2.32 times its book value. This may indicate undervaluation.

2.32

EV/EBITDA

Enterprise value stands at -14.15 times EBITDA. This is generally considered low.

-14.15

How Well Does GRAL Make Money?

Net Profit Margin

For every $100 in sales, GRAIL Inc. keeps $-2.37 as profit after all expenses.

-2.37%

Operating Margin

Core operations generate -3.38 in profit for every $100 in revenue, before interest and taxes.

-3.38%

ROE

Management delivers $-15.88 in profit for every $100 of shareholder equity.

-15.88%

ROA

GRAIL Inc. generates $-13.77 in profit for every $100 in assets, demonstrating efficient asset deployment.

-13.77%

Following the Money - Real Cash Generation

Operating Cash Flow

GRAIL Inc. generates limited operating cash flow of $-293.41M, signaling weaker underlying cash strength.

$-293.41M

Free Cash Flow

GRAIL Inc. generates weak or negative free cash flow of $-293.91M, restricting financial flexibility.

$-293.91M

FCF Per Share

Each share generates $-6.85 in free cash annually.

$-6.85

FCF Yield

GRAL converts -5.10% of its market value into free cash.

-5.10%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-14.05

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.45

vs 25 benchmark

P/B Ratio

Price to book value ratio

2.32

vs 25 benchmark

P/S Ratio

Price to sales ratio

35.56

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.04

vs 25 benchmark

Current Ratio

Current assets to current liabilities

10.95

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.16

vs 25 benchmark

ROA

Return on assets percentage

-0.14

vs 25 benchmark

ROCE

Return on capital employed

-0.20

vs 25 benchmark

How GRAL Stacks Against Its Sector Peers

MetricGRAL ValueSector AveragePerformance
P/E Ratio-14.0530.63 Better (Cheaper)
ROE-15.88%570.00% Weak
Net Margin-236.95%24326.00% Weak
Debt/Equity0.040.52 Strong (Low Leverage)
Current Ratio10.955.69 Strong Liquidity
ROA-13.77%-59.00% (disorted) Weak

GRAL outperforms its industry in 3 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews GRAIL Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

0.00%

Industry Style: Defensive, Growth, Innovation

Declining

EPS CAGR

-340.16%

Industry Style: Defensive, Growth, Innovation

Declining

FCF CAGR

-333.65%

Industry Style: Defensive, Growth, Innovation

Declining

Fundamental Analysis FAQ